Medigus MDGS shares are trading higher on Tuesday after the company announced it was informed by Smart Repair Pro that all of Amazon's required regulatory processes were completed, which allows for the opening of its store in the UK, France, Italy, Germany and Spain.
Medigus is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease).
Medigus shares traded up 57.78% to $2.98 on Tuesday at the time of publication. The stock has a 52-week high of $5.15 and a 52-week low of 83 cents.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
